๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of a neutral gadolinium chelate as a contrast medium for ERCP: case report

โœ Scribed by Fauze Maluf-Filho; Manoel Souza Rocha; Paulo Sakai

Book ID
118525338
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
116 KB
Volume
61
Category
Article
ISSN
1097-6779

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A new lipophilic gadolinium chelate as a
A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI
โœ H.-J. Weinmann; G. Schuhmann-Giampieri; H. Schmitt-Willich; H. Vogler; T. Frenze ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 280 KB

## Abstract Gdโ€Ethoxybenzylโ€DTPA (Gdโ€EOBโ€DTPA) is a highly waterโ€soluble paramagnetic contrast agent. Due to its protein binding of about 10% and its lipophilic residue, Gdโ€EOBโ€DTPA exhibits both renal (30% of the dose) and hepatobiliary (70%) excretion in rats. Despite its lipohilic character, the

Biliary excretion and pharmacokinetics o
Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat
โœ Gabriele Schuhmann-Giampieri; Heribert Schitt-Willich; Thomas Frenzel ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 735 KB

The introduction of a lipophilic moiety into the gadolinium chelate Gd-DTPA (dimeglumine gadopentetate, Magnevist) yielded Gd-EOB-DTPA (short form), which has potential as a magnetic resonance contrast agent for liver mass screening. The pharmacokinetics of Gd-EOB-DTPA in rats is nonlinear because a